VOR Form 4: Reprogrammed Interchange LLC Sells 667,536 Shares at ~$2.09

Rhea-AI Filing Summary

Reprogrammed Interchange LLC, an entity associated with Reid Hoffman, reported sales of common stock of Vor Biopharma Inc. (VOR) on August 25-26, 2025. The filing shows 387,346 shares sold on 08/25/2025 at a weighted average price of $2.1163, and 284,190 shares sold on 08/26/2025 at a weighted average price of $2.0808. Following the 08/25 sale the filing reports 38,586,755 shares beneficially owned by Reprogrammed and after the 08/26 sale 38,302,565 shares were reported.

The filer states the shares are held by Reprogrammed Interchange LLC and that Reid Hoffman may be deemed a beneficial owner by virtue of shared control and indirect pecuniary interest, while disclaiming beneficial ownership except to the extent of his pecuniary interest. The transactions were signed on 08/27/2025 by Frank Huang, Manager of Reprogrammed Interchange LLC, and Reid Hoffman.

Positive

• Transparent disclosure of sale quantities, weighted average prices, and post-transaction beneficial ownership
• Clear identification of reporting persons and their relationship to the issuer (Director and 10% owner)
• Willingness to provide per-trade price breakdowns upon request, improving traceability

Negative

• Large insider dispositions: combined sale of 667,536 shares over two days may be viewed negatively by some investors
• Limited context in the filing about the reason for sales or whether they were pursuant to a trading plan

Insights

Financial Analyst

TL;DR: Substantial insider sales totaling 667,536 shares across two days; disclosure shows weighted average prices and post-sale holdings.

The Form 4 discloses coordinated sales by an affiliate of a director and 10% owner over two trading days. Combined, the reported dispositions total 667,536 shares at weighted average prices of $2.1163 and $2.0808. The filing gives clear post-transaction beneficial ownership figures, which help quantify the remaining stake. For valuation context, an analyst would multiply reported share counts by the sale prices to estimate proceeds, but that calculation is not included in the filing and is not performed here. The disclosure conforms to Section 16 reporting norms and includes the filers offer to provide per-trade price breakdowns upon request.

Corporate Governance Expert

TL;DR: Filing documents required insider sales and clarifies beneficial ownership and disclaimers; governance disclosure appears complete.

The Form 4 identifies the reporting entity, relationship to the issuer (Director and 10% owner), and provides explanatory footnotes about shared control and disclaimers by Reid Hoffman. The signature block indicates timely execution. The filing notes multiple trades with weighted average prices and offers additional per-trade detail on request, which is good governance practice for transparency. No amendments or 10b5-1 plan box are indicated in the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reprogrammed Interchange LLC

(Last) (First) (Middle)

101 MISSION STREET, SUITE 1000

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vor Biopharma Inc. [ VOR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		S		387,346	D	$2.1163(1)	38,586,755(2)	D
Common Stock	08/26/2025		S		284,190	D	$2.0808(3)	38,302,565(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Reprogrammed Interchange LLC

(Last) (First) (Middle)

101 MISSION STREET, SUITE 1000

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Hoffman Reid

(Last) (First) (Middle)

101 MISSION STREET, SUITE 1000

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $2.05 to $2.215. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

2. The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

3. This transaction was executed in multiple trades at prices ranging from $2.06 to $2.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

	/s/ Frank Huang, Manager of Reprogrammed Interchange LLC	08/27/2025
	/s/ Reid Hoffman	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Reprogrammed Interchange LLC sell in the VOR Form 4?

The filing reports sales of 387,346 shares on 08/25/2025 and 284,190 shares on 08/26/2025 of Vor Biopharma Inc. common stock.

At what prices were the VOR shares sold according to the Form 4?

The weighted average sale prices reported are $2.1163 for 08/25/2025 and $2.0808 for 08/26/2025, with per-trade ranges disclosed in footnotes.

How many VOR shares did the reporting person beneficially own after the reported sales?

The filing reports 38,586,755 shares after the 08/25 sale and 38,302,565 shares after the 08/26 sale.

Does Reid Hoffman claim ownership of the shares held by Reprogrammed Interchange LLC?

The filing states Reid Hoffman may be deemed a beneficial owner due to shared control and indirect pecuniary interest but expressly disclaims beneficial ownership except to the extent of his pecuniary interest.

Who signed the Form 4 for these VOR transactions and when?

The Form 4 is signed by Frank Huang, Manager of Reprogrammed Interchange LLC and by Reid Hoffman, both dated 08/27/2025.